Bruker BioScience Shareholders Approve Acquisition of Bruker Optics
Bruker BioSciences shareholders overwhelmingly voted to approve the acquisition of molecular spectroscopy company Bruker Optics at this week's annual meeting, the company said.
The $135 million deal, announced in April [PM 04-20-06], would be paid approximately 59 percent in cash and 41 percent in the company's stock.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
